The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT07036835




Registration number
NCT07036835
Ethics application status
Date submitted
17/06/2025
Date registered
25/06/2025
Date last updated
25/06/2025

Titles & IDs
Public title
Clinical Investigation of a Femtosecond Laser for Corneal Flap Creation
Scientific title
Clinical Investigation of the WaveLight® Ultraviolet Femtosecond Laser for Corneal Flap Creation
Secondary ID [1] 0 0
RFO268-C009
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Refractive Errors 0 0
Condition category
Condition code
Eye 0 0 0 0
Diseases / disorders of the eye

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Surgery - LASIK Surgery
Treatment: Devices - UV fs-Laser
Treatment: Devices - IR fs-Laser
Treatment: Devices - Anesthetic 1 eye drops
Treatment: Devices - Anesthetic 2 eye drops

Other: UV fs-Laser/Anesthetic 1 Right, IR fs-Laser/Anesthetic 1 Left - LASIK surgery performed with the UV fs-Laser (right eye) and IR fs-Laser (left eye) as randomized with Anesthetic 1 eye drops

Other: UV fs-Laser/Anesthetic 1 Left, IR fs-Laser/Anesthetic 1 Right - LASIK surgery performed with the UV fs-Laser (left eye) and IR fs-Laser (right eye) as randomized with Anesthetic 1 eye drops

Other: UV fs-Laser/Anesthetic 2 Right, IR fs-Laser/Anesthetic 2 Left - LASIK surgery performed with the UV fs-Laser (right eye) and IR fs-Laser (left eye) as randomized with Anesthetic 2 eye drops

Other: UV fs-Laser/Anesthetic 2 Left, IR fs-Laser/Anesthetic 2 Right - LASIK surgery performed with the UV fs-Laser (left eye) and IR fs-Laser (right eye) as randomized with Anesthetic 2 eye drops


Treatment: Surgery: LASIK Surgery
Laser assisted in situ keratomileusis (LASIK) surgery conducted for the purpose of correcting refractive error

Treatment: Devices: UV fs-Laser
WaveLight Ultraviolet Femtosecond Laser used for creating a corneal flap during LASIK surgery

Treatment: Devices: IR fs-Laser
WaveLight FS200 Infrared Femtosecond Laser used for creating a corneal flap during LASIK surgery

Treatment: Devices: Anesthetic 1 eye drops
Topical anesthetic used to numb the surface of the eye

Treatment: Devices: Anesthetic 2 eye drops
Topical anesthetic used to numb the surface of the eye

Intervention code [1] 0 0
Treatment: Surgery
Intervention code [2] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Difference of intended and achieved flap thickness measured at center (i.e., corneal apex)
Timepoint [1] 0 0
Month 1
Primary outcome [2] 0 0
Difference of flap thickness measured between central (i.e., corneal apex) and periphery (i.e., 3 millimeter radius)
Timepoint [2] 0 0
Month 1
Primary outcome [3] 0 0
Ability to lift flap at time of surgery
Timepoint [3] 0 0
Day 0 Surgery
Primary outcome [4] 0 0
Ocular adverse events (AEs) related to corneal flap creation with UV fs-Laser and IR fs-Laser
Timepoint [4] 0 0
Day 0 Surgery up through Month 3
Primary outcome [5] 0 0
Flap-related loss of best-corrected distance visual acuity (BCDVA) greater than or equal to 2 lines (greater than or equal to 10 letters logMAR) at 1 month postoperative or later
Timepoint [5] 0 0
Month 1 up to Month 3
Primary outcome [6] 0 0
Number of device deficiencies
Timepoint [6] 0 0
Day 0 Surgery through Month 3

Eligibility
Key inclusion criteria
Key

* Eligible for LASIK treatment;
* Myopia as specified in the protocol;
* Uncorrected distance visual acuity of greater than or equal to 0.30 logMAR;
* Best corrected distance visual acuity of less than or equal to 0.10 logMAR;
* Presence of clear natural lens (non-cataractous eye);
* Other protocol-defined inclusion criteria may apply.

Key
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* An active implanted device for which laser use may be a contraindication;
* Previous ocular surgery;
* Ocular conditions that may affect subject safety or impact study outcomes;
* Acute or chronic disease or illness that would increase the operative risk or confound the outcomes of the study;
* Current use of medications with known ocular side effects and photosensitivity;
* Other protocol-defined exclusion criteria may apply.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW
Recruitment hospital [1] 0 0
Personaleyes - Sydney
Recruitment postcode(s) [1] 0 0
2000 - Sydney

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Alcon Research
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Clinical Trial Lead, Surgical
Address 0 0
Alcon Research, LLC
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Alcon Call Center
Address 0 0
Country 0 0
Phone 0 0
1-888-451-3937
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

No documents have been uploaded by study researchers.